Stryker (SYK) Competitors

Stryker (NYSE:SYK) and Abbott Laboratories (NYSE:ABT) are both large-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, institutional ownership, community ranking, media sentiment, valuation, profitability and risk.

Which has stronger earnings and valuation, SYK or ABT?

Abbott Laboratories has higher revenue and earnings than Stryker. Abbott Laboratories is trading at a lower price-to-earnings ratio than Stryker, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Stryker	$20.50B	7.23	$3.17B	$9.33	41.66
Abbott Laboratories	$41.22B	4.93	$5.72B	$3.29	35.59

Does the media refer more to SYK or ABT?

In the previous week, Abbott Laboratories had 6 more articles in the media than Stryker. MarketBeat recorded 46 mentions for Abbott Laboratories and 40 mentions for Stryker. Abbott Laboratories' average media sentiment score of 1.50 beat Stryker's score of 1.30 indicating that Abbott Laboratories is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Stryker	32 Very Positive mention(s)	0 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Abbott Laboratories	45 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do insiders & institutionals have more ownership in SYK or ABT?

77.1% of Stryker shares are owned by institutional investors. Comparatively, 75.2% of Abbott Laboratories shares are owned by institutional investors. 5.5% of Stryker shares are owned by insiders. Comparatively, 0.5% of Abbott Laboratories shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Is SYK or ABT a better dividend stock?

Stryker pays an annual dividend of $3.20 per share and has a dividend yield of 0.8%. Abbott Laboratories pays an annual dividend of $2.20 per share and has a dividend yield of 1.9%. Stryker pays out 34.3% of its earnings in the form of a dividend. Abbott Laboratories pays out 66.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Stryker has raised its dividend for 31 consecutive years and Abbott Laboratories has raised its dividend for 53 consecutive years. Abbott Laboratories is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Do analysts rate SYK or ABT?

Stryker currently has a consensus price target of $393.65, suggesting a potential upside of 1.28%. Abbott Laboratories has a consensus price target of $130.07, suggesting a potential upside of 11.07%. Given Abbott Laboratories' higher probable upside, analysts plainly believe Abbott Laboratories is more favorable than Stryker.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Stryker	0 Sell rating(s)	4 Hold rating(s)	16 Buy rating(s)	0 Strong Buy rating(s)	2.80
Abbott Laboratories	0 Sell rating(s)	4 Hold rating(s)	12 Buy rating(s)	0 Strong Buy rating(s)	2.75

Does the MarketBeat Community favor SYK or ABT?

Abbott Laboratories received 17 more outperform votes than Stryker when rated by MarketBeat users. Likewise, 69.70% of users gave Abbott Laboratories an outperform vote while only 64.71% of users gave Stryker an outperform vote.

Company	Underperform	Outperform
Stryker	Outperform Votes 917 64.71%	Underperform Votes 500 35.29%
Abbott Laboratories	Outperform Votes 934 69.70%	Underperform Votes 406 30.30%

Which has more volatility & risk, SYK or ABT?

Stryker has a beta of 0.91, indicating that its share price is 9% less volatile than the S&P 500. Comparatively, Abbott Laboratories has a beta of 0.72, indicating that its share price is 28% less volatile than the S&P 500.

Is SYK or ABT more profitable?

Stryker has a net margin of 16.34% compared to Abbott Laboratories' net margin of 13.99%. Stryker's return on equity of 23.07% beat Abbott Laboratories' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Stryker	16.34%	23.07%	11.04%
Abbott Laboratories	13.99%	20.18%	10.84%

Summary

Stryker beats Abbott Laboratories on 12 of the 21 factors compared between the two stocks.